(‘Netscientific’ or ‘the Company’)
Notification of Results
Netscientific, the biomedical and healthcare technology investment group, will announce its full year results for the year ended 31 December 2013 on Wednesday 19 March 2014.
A presentation for analysts, hosted by the management team, will be held at 9:00am GMT on Wednesday 19th March 2014.
Analysts are invited to attend the presentation. If you would like to attend please contact Kashara Taylor, Bell Pottinger, Tel: 020 7861 3032 or email@example.com.
For further information, please contact:
Liberum (Nomad & Broker)
Chris Bowman / Christopher Britton / Thomas Bective
Tel: 020 3100 2000
Daniel de Belder/Kashara Taylor
Tel: 020 7861 3232
Company website: www.netscientific.net
NetScientific is a healthcare medical technology company that identifies, develops and commercialises research and technologies originating from leading universities, teaching hospitals and research institutes globally, particularly in the United Kingdom and the United States. The Group is primarily focused on identifying and developing research and technologies for use in five chronic disease areas within the healthcare diagnostics sector: (i) cardiovascular; (ii) liver; (iii) cancer; (iv) metabolic; and (v) digital health.